Obstetrics/Gynecology CME

The Northwestern University Feinberg School of Medicine offers various up to date CME activities that offer CME credits.

Topics include:
Neuro-oncology, Cardiovascular Health, Echocardiographic Assessment, and many more.

Target Audience: Various Specialties

Popular activities include:
• Treatment of the Woman with Refractory Overactive Bladder
• Diagnostic Testing for Rupture of Membranes:
• Performance of ROM Diagnostics in Clinically Relevant Populations
• Updates in HPV Testing and Genotyping
• Screening and Maternal Fetal Rh Incompatibility
• HPV Screening & Testing
• Managing Osteoporotic Fracture Risk

Target Audience: Physicians focusing on OB/GYN, Internal Medicine, and Family Medicine.

You will find five areas presenting new CME on a monthly basis:

Cardiology Corner activities include a combined slide and audio presentation, as well as mp3, mp4, and a non-audio option.

Supplemental Reading/References provide links to abstracts.

Grand Rounds contains evidence-based topic presentations and discussions.

The Radiology Wing and Pathology Gallery presents a new picture or X-ray.

The Ultrasound Wing features case presentations with ultrasound images. Instruction is via a brief text or graphics case followed by online discussion among the users and then a brief multiple choice test.

Target Audience:
PED (Neonatology), Maternal and Fetal Medicine (Perinatology).

ReachMD consists entirely of podcasts offering 0.25 to 0.75 credit-hours. These can be listened to on your computer, mp3 player, XM Satellite radio or iPhone. Most activities are in general adult medicine and OB/GYN.

Target Audience: Physicians focusing on Family Medicine, Internal Medicine, and OB-GYN.

Expert Gynecologic Pathology CME

Gynecologic Pathology focuses on lesions occurring in the female genital system, including classification guidelines, revised terminology and diagnostic pearls. Continuing medical education lectures and microscopy sessions are organized by anatomic location and type of diagnosis: inflammatory, neoplastic, low grade, high grade. Part of our Masters of Pathology Series, this online CME course will help you in:

• Classifying tumors using histologic criteria for prognosis
• Applying the correct algorithm to diagnoses
• Using recently discovered immunohistochemistry antibodies and molecular data

Learning Objectives

At the conclusion of this CME activity, the participant will be able to:

• Recognize the main inflammatory conditions of the vulva
• Be familiar with the concepts in squamous intraepithelial neoplasia
• Diagnose and apply histologic criteria for prognosis of endocervical carcinoma
• Recognize the histologic types of endometrial carcinoma
• Apply universal testing to detect Lynch syndrome patients
• Recognize the main mesenchymal tumors of the uterus and the most useful ancillary tests for diagnosis
• Diagnose precursor lesions of serous carcinogenesis in the fallopian tube
• Distinguish between clear cell, endometrioid and serous carcinomas of the ovary
• Be familiar with germ cell and sex cord stromal tumors of the ovary
• Navigate through the main diagnostic challenges in placental pathology

Intended Audience

This educational activity is intended for training and practicing pathologists and gynecologists.

Endometrial cancer, a type of cancer that originates in the lining of the uterus, is the most common gynecologic cancer and the fourth most common cancer in women living in the United States. The vast majority of women are diagnosed with endometrial cancer after the age of 50, and the most common risk factors are obesity, diabetes, hypertension, and increasing age. Levels of the two hormone estrogen and progesterone fluctuate during the menstrual cycle, resulting in cell proliferation and differentiation that may lead to abnormalities that contribute to malignancies later in life. The costs associated with endometrial cancer may amount to tens of thousands of dollars per patient, depending on the stage of disease upon diagnosis.

By the end of the session the participant will be able to:

• Review guideline-recommended therapy for advanced and recurrent endometrial cancer
• Distinguish between the different forms of therapy presently approved for advanced or recurrent endometrial cancer and apply them to practice
• Describe investigational therapies for advanced or recurrent endometrial cancer and their anticipated place in therapy
• Describe the challenges and barriers to care associated with treating patients with advanced or recurrent endometrial cancer

Target Audience:

The following HCPs: medical oncologists; physician assistants, nurse practitioners, and pharmacists who practice in oncology; and other clinicians who commonly encounter patients with recurrent or advanced endometrial cancer.